J.P. Turner & Co Capital Management’s AstraZeneca AZN Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,485	Closed	-$224K	–	186
2015 Q2	$224K	Sell	3,485 -249	-7%	-$17K	0.17%	185
2015 Q1	$258K	Buy	+3,734	New	+$259K	0.24%	135

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

J.P. Turner & Co Capital Management's AZN Position: Q3 2015 in Review

J.P. Turner & Co Capital Management sold out of AstraZeneca (AZN) in Q3 2015, closing a stake of 3,485 shares — an estimated $224K sold.

J.P. Turner & Co Capital Management first reported a position in AZN in Q1 2015 and held it in 2 quarters. The position peaked at $258K in Q1 2015. 371 funds tracked by Wall St. Rank hold AZN as of Q3 2015.

J.P. Turner & Co Capital Management reported no remaining AstraZeneca position as of Q3 2015 after selling out during the quarter.
J.P. Turner & Co Capital Management sold 3,485 AstraZeneca shares in Q3 2015, an estimated $224K.
J.P. Turner & Co Capital Management first reported a position in AstraZeneca in Q1 2015 and held it in 2 quarters.
J.P. Turner & Co Capital Management's AstraZeneca position peaked at $258K in Q1 2015.
371 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.